Tamoxifen Completed Phase 2 Trials for Gliomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00108069Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors